The bacteria that cause tuberculosis are experts at survival, allowing the disease to persist even when faced with the immune system and drugs. Harvard T.H. Chan School of Public Health’s Sarah Fortune is on a mission to figure out why. Of all the health problems that dominate our thoughts and anxieties, tuberculosis (TB) probably ranks low … Continue reading “In pursuit of an elusive foe”
BPH faculty member, Sarah Merritt Fortune, has been promoted to Professor of Immunology and Infectious Diseases in the Department of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health. Spanning the field from molecules to populations, Dr. Fortune’s research has focused on Mycobacterium tuberculosis (Mtb) using novel genetic tools and new technologies to study the … Continue reading “Sarah Merritt Fortune promoted to Tenured Professor”
Diacetyl, a flavoring chemical linked to cases of severe respiratory disease, was found in more than 75% of flavored electronic cigarettes and refill liquids tested by researchers at Harvard T.H. Chan School of Public Health. Two other potentially harmful related compounds were also found in many of the tested flavors, which included varieties with potential … Continue reading “Chemicals linked with severe respiratory disease found in common e-cigarette flavors”
Cutting-edge work on molecular mechanisms involved in the cellular response to stress was the focus at the 18th annual John B. Little Symposium, held October 23-24, 2015 at Harvard T.H. Chan School of Public Health. The symposium is hosted each year by the John B. Little (JBL) Center for Radiation Sciences. Both the symposium and the center … Continue reading “Symposium gathers experts on oxidative stress and mitochondria”
An international team unravels the genetic basis for the protective effects of the RTS,S malaria vaccine — the first candidate vaccine to win approval by European health officials. Last month, the public health community marked one of the most significant biomedical milestones in the fight against malaria in nearly half a century: European regulators … Continue reading “Dissecting the power of a historic malaria vaccine”
Two faculty members from Harvard T.H. Chan School of Public Health—Xihong Lin and Brendan Manning—will receive prestigious National Cancer Institute Outstanding Investigator Awards (OIA). These multimillion-dollar seven-year awards, providing extended funding stability, are aimed at giving promising and productive investigators enough time and money to continue or embark on projects of unusual potential in cancer research—and to take greater … Continue reading “Brendan Manning, Xihong Lin receive prestigious NCI awards”
A Special Report by Amy Gutman, Boston-based writer, and Madeline Drexler, editor, Harvard Public Health To see the original article, please click here. The Gray Wave. The Silver Tsunami. The Agequake. Aging societies have been on the horizon for decades, not just in the United States but also around the world. The driving forces are well-established: … Continue reading “The Aging Game”
The roots of the current Syrian crisis may be found in the massive drought that afflicted the country between 2006 and 2009 and precipitated a migration of more than 1 million people from rural to urban areas. According to Harvard T.H. Chan School of Public Health researchers speaking at an event during the inaugural HUBweek, … Continue reading “At HUBweek, experts focus on global health threats”
Public health practitioners, policy makers, and industry representatives from China and the U.S. gathered September 28–29, 2015, to share experiences and ideas around health system reform. The 5th U.S.–China Summit, hosted by Harvard T.H. Chan School of Public Health at the Joseph B. Martin Conference Center, included for the first time a forum and innovation … Continue reading “Summit brings together U.S., China health leaders”
If you’re looking for a miracle drug that cuts heart attack and diabetes risk by 80 and 90 percent, respectively, and also reduces the danger of cancer, stroke, and late-life cognitive decline, just close the medicine cabinet door. Look in the mirror instead. Despite recent headlines on potentially revolutionary cholesterol-lowering drugs, panelists in a recent … Continue reading “A strong start toward good health: Good choices”